Background <p>Given the limitations of gait speed tests for sarcopenia assessment, this study evaluated the Elbow Performance Test (EPT), a simple upper-extremity alternative.</p> Aims <p>This study aimed to evaluate the test-retest reliability of the EPT and its ability to distinguish between older adults with sarcopenia and healthy young controls.</p> Methods <p>This cross-sectional study included 96 male participants: 43 older adults with sarcopenia (≥60 years) and 53 healthy young controls (≤40 years). Assessments covered muscle strength, mass, and physical performance, including 4-meter gait speed, the Short Physical Performance Battery (SPPB), and Timed Up and Go (TUG). The EPT required 30 self-paced elbow flexion-extension repetitions with a 1-kg weight. Test-retest reliability was assessed after 7–10 days using intraclass correlation coefficients (ICCs).</p> Results <p>All performance test scores differed significantly between the sarcopenia and control groups (<i>p</i> &lt; 0.01). The EPT showed excellent test–retest reliability in both the control (ICC = 0.932; 95% CI:0.885–0.960) and sarcopenia (ICC = 0.905; 95% CI:0.831–0.947) groups. In terms of reliability, the EPT outperformed gait speed and SPPB in both groups and was comparable to the TUG test in the sarcopenic group.</p> Conclusions <p>The EPT demonstrated excellent reliability and effectively distinguished between older adults with sarcopenia and healthy controls. Given its simplicity, high repeatability, and minimal equipment needs, the EPT may serve as a practical tool for assessing upper-extremity muscle performance, particularly in settings where traditional lower-extremity-based tests are less feasible. Further studies are warranted to confirm its broader clinical utility across diverse populations.</p> Clinical trial registration <p>This trial was retrospectively registered at ClinicalTrials.gov (Identifier: NCT07065448) on July 03, 2025.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A novel upper-extremity-based performance test for sarcopenia: reliability and clinical utility of the elbow performance test

  • Taha Yasin Yildirim,
  • Eser Kalaoglu,
  • Tugba Aydin,
  • Kemal Sitki Türker,
  • Ilhan Karacan

摘要

Background

Given the limitations of gait speed tests for sarcopenia assessment, this study evaluated the Elbow Performance Test (EPT), a simple upper-extremity alternative.

Aims

This study aimed to evaluate the test-retest reliability of the EPT and its ability to distinguish between older adults with sarcopenia and healthy young controls.

Methods

This cross-sectional study included 96 male participants: 43 older adults with sarcopenia (≥60 years) and 53 healthy young controls (≤40 years). Assessments covered muscle strength, mass, and physical performance, including 4-meter gait speed, the Short Physical Performance Battery (SPPB), and Timed Up and Go (TUG). The EPT required 30 self-paced elbow flexion-extension repetitions with a 1-kg weight. Test-retest reliability was assessed after 7–10 days using intraclass correlation coefficients (ICCs).

Results

All performance test scores differed significantly between the sarcopenia and control groups (p < 0.01). The EPT showed excellent test–retest reliability in both the control (ICC = 0.932; 95% CI:0.885–0.960) and sarcopenia (ICC = 0.905; 95% CI:0.831–0.947) groups. In terms of reliability, the EPT outperformed gait speed and SPPB in both groups and was comparable to the TUG test in the sarcopenic group.

Conclusions

The EPT demonstrated excellent reliability and effectively distinguished between older adults with sarcopenia and healthy controls. Given its simplicity, high repeatability, and minimal equipment needs, the EPT may serve as a practical tool for assessing upper-extremity muscle performance, particularly in settings where traditional lower-extremity-based tests are less feasible. Further studies are warranted to confirm its broader clinical utility across diverse populations.

Clinical trial registration

This trial was retrospectively registered at ClinicalTrials.gov (Identifier: NCT07065448) on July 03, 2025.